Found: 17
Select item for more details and to access through your institution.
Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 5, p. 760, doi. 10.1002/ajh.26892
- By:
- Publication type:
- Article
Clinico‐genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 398, doi. 10.1002/ajh.26799
- By:
- Publication type:
- Article
Safety, Feasibility, and Effects of Short-Term Calorie Reduction during Induction Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma: A Pilot Study.
- Published in:
- Nutrients, 2021, v. 13, n. 9, p. 3268, doi. 10.3390/nu13093268
- By:
- Publication type:
- Article
Feasibility, Process, and Effects of Short-Term Calorie Reduction in Cancer Patients Receiving Chemotherapy: An Integrative Review.
- Published in:
- Nutrients, 2020, v. 12, n. 9, p. 2823, doi. 10.3390/nu12092823
- By:
- Publication type:
- Article
Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities.
- Published in:
- Journal of Biomedical Science, 2023, v. 30, n. 1, p. 1, doi. 10.1186/s12929-022-00893-0
- By:
- Publication type:
- Article
Treatment benefit of upfront autologous stem cell transplantation for newly diagnosed multiple myeloma: a systematic review and meta-analysis.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10907-1
- By:
- Publication type:
- Article
Busulfan‐containing conditioning regimens in allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: A Taiwan observational study.
- Published in:
- Cancer Reports, 2022, v. 5, n. 3, p. 1, doi. 10.1002/cnr2.1488
- By:
- Publication type:
- Article
Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01031-9
- By:
- Publication type:
- Article
Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-023-00975-8
- By:
- Publication type:
- Article
Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00894-8
- By:
- Publication type:
- Article
Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-022-00774-7
- By:
- Publication type:
- Article
Chronic disseminated candidiasis manifesting as hepatosplenic abscesses among patients with hematological malignancies.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A case of acute myelomonocytic leukemia morphologically mimicking lymphoblastic leukemia.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromes.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 3, p. 463, doi. 10.1002/hon.3109
- By:
- Publication type:
- Article
Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 2, p. 349, doi. 10.1007/s00277-021-04711-9
- By:
- Publication type:
- Article
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax.
- Published in:
- 2020
- By:
- Publication type:
- journal article